Brief: Renovorx Reports Third Quarter 2022 Financial Results
14/11/2022 18:26
Nov 14 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* RENOVORX INC - QTRLY NET LOSS WAS $2.1 MILLION FOR QUARTER
ENDED
ON SEPTEMBER 30, 2022
Source text for Eikon: ID:nBw5YCTGHa
Further company coverage: RNXT.O
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer